SMTL ID : 2i5x.1 (1 other biounit)

Engineering the PTPbeta catalytic domain with improved crystallization properties

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 5 residues within 4Å: Chain A: R.83, V.84, D.96, Y.97, I.98 Ligand excluded by PLIP

1 x UA5: (4-ETHYLPHENYL)SULFAMIC ACID(Non-covalent)

UA5.2: 12 residues within 4Å: Chain A: Y.73, I.76, D.210, H.211, C.244, S.245, A.246, G.247, V.248, G.249, R.250, Q.288 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:Y.73, A:Y.73, A:I.76, A:A.246, A:V.248 Hydrogen bonds: A:D.210, A:S.245, A:A.246, A:G.247, A:V.248, A:G.249, A:R.250 Water bridges: A:D.210, A:Q.292 Salt bridges: A:R.250 pi-Cation interactions: A:H.211

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Evdokimov, A.G. et al., Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery. Acta Crystallogr.,Sect.D (2006)

Release Date

2006-09-05

Peptides

Receptor-type tyrosine-protein phosphatase beta: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Receptor-type tyrosine-protein phosphatase beta

Related Entries With Identical Sequence